Please assess the completion status of the following clinical trial:

Trial Title: Prophylactic Use of Antibiotics for Through and Through Lacerations of the Lip

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* any individual who presents with a through-and-through laceration of the lip within twenty-four hours of injury~Exclusion Criteria:~* patients less than eighteen years of age~* pregnancy~* currently taking antibiotics~* animal or human bites~* wounds greater than 24 hours old~* diabetic patients~* immune compromised patients~* patients who require antibiotics for other sustained injuries~* patients with an allergy to penicillin or cephalosporin will be excluded if randomized to the cephalexin treatment group

- Gender: ALL
- Minimum Age: 18 Months
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- keflex (Type: EXPERIMENTAL): keflex 500mg twice a day for five days
- placebo (Type: PLACEBO_COMPARATOR): placebo 500mg twice a day for five days

Based on this trial design, predict the completion outcome and termination type (if applicable).